Investigating a specific form of the Huntingtin protein in Huntington's Disease
Examining the Role of a Pathogenic HTT Isoform, HTT1a, in Somatic Expansion and RNA Aggregation in Huntington's Disease
This study is looking at a special version of a protein called HTT1a to see how it affects Huntington's Disease and how it interacts with the harmful parts of the disease, with the hope of finding new ways to help improve treatments for people living with HD.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Massachusetts Med Sch Worcester NIH-funded |
| Lab location | 1 site (Worcester, United States) |
| Project ID | NIH-10902689 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of a specific isoform of the Huntingtin protein, known as HTT1a, in the progression of Huntington's Disease (HD). It aims to explore how HTT1a interacts with mutant Huntingtin mRNA and protein aggregates, which are linked to the disease's symptoms. By using small interfering RNA (siRNA) techniques, the study will investigate the mechanisms that lead to the production of HTT1a and its impact on the disease's progression. The goal is to identify new therapeutic targets that could improve treatment options for patients with HD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Huntington's Disease, particularly those with expanded CAG repeats in the HTT gene.
Not a fit: Patients without a diagnosis of Huntington's Disease or those with other unrelated neurological disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies that slow down or alter the progression of Huntington's Disease.
How similar studies have performed: While the specific approach of targeting HTT1a is novel, similar research has shown promise in understanding the molecular mechanisms of Huntington's Disease.
Where this research is happening
Worcester, United States
- Univ of Massachusetts Med Sch Worcester — Worcester, United States (Active)
Researchers
- Principal investigator: Allen, Sarah Jane — Univ of Massachusetts Med Sch Worcester
- Study coordinator: Allen, Sarah Jane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.